Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction

Similar documents
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction

Undetectable High-Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction

Dolore Toracico e Livelli di Troponina non Misurabili

Mario Plebani University-Hospital of Padova, Italy

BioRemarkable Symposium

EARLY DIAGNOSIS AND RISK STRATIFICATION IN PATIENTS WITH SYMPTOMS SUGGESTIVE OF ACUTE CORONARY SYNDROME

High-Sensitivity Cardiac Troponin T Concentrations below the Limit of Detection to Exclude Acute Myocardial Infarction: A Prospective Evaluation

High Sensitivity Troponin Improves Management. But Not Yet

DIAGNOSTICS ASSESSMENT PROGRAMME

EDUCATIONAL COMMENTARY CARDIAC FUNCTION: BIOCHEMICAL MARKERS UPDATE

Defining rise and fall of cardiac troponin values

Troponin when is an assay high sensitive?

Low concentrations of high-sensitivity troponin T at presentation to the

Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a sensitive troponin I assay

Use of Biomarkers for Detection of Acute Myocardial Infarction

10 Ways to Make the Use of High Sensitivity Cardiac Troponin Values Easier and Better

High Sensitivity Troponins. IT S TIME TO SAVE LIVES. Updates from the ESC 2015 Guidelines November 17th 2016 OPL CONGRESS Dr.

hs-c Tn I high sensitivity troponin I <17 min

Prospective Validation of a Clinical Decision Rule to Identify ED Chest Pain Patients Who Can Safely be Removed from Cardiac Monitoring

TYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016

Supplementary Online Content

Keywords Acute coronary syndromes, High sensitivity cardiac markers, Malta, Troponin T, Myocardial infarction

The clinical performance of the novel POC Minicare ctni-assay. Per Venge, MD PhD Professor in Clinical Chemistry Uppsala University Uppsala, Sweden

Myocardial Infarction In Dr.Yahya Kiwan

Title:Determinants of high sensitivity cardiac troponin T elevation in acute ischemic stroke

7/31/2018. Overview of Next Generation Cardiac Troponin T High Sensitivity. Disclosures. Course Objectives: high sensitive Troponin T assay

CARDIOLOGY GRAND ROUNDS

Title:Determinants of high sensitivity cardiac troponin T elevation in acute ischemic stroke

Congreso Nacional del Laboratorio Clínico 2016

D DAVID PUBLISHING. 1. Introduction. 2. Methods. Samira Green 1, Vanessa Jessop 2, Jason Pott 2 and Tim Harris 2

Diagnostics guidance Published: 1 October 2014 nice.org.uk/guidance/dg15

Diagnostics consultation document

Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest pain

High-Sensitivity Cardiac Troponin in Suspected ACS

TROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained?

CARDIOLOGY GRAND ROUNDS

Acute Coronary Syndrome

Patient characteristics Intervention Comparison Length of followup

How will new high sensitive troponins affect the criteria?

Recent community campaigns on

Cardiac Troponin Testing and Chest Pain Patients: Exploring the Shades of Gray

GSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:

Evaluation of the optimal myocardial infarction cutoff for the PATHFAST Troponin I assay of Mitsubishi Kagaku Iatron (MKI)

Clinical Considerations of High Sensitivity Troponins

Characteristics of Transient ST-Elevation versus ST-Elevation and Non-ST-Elevation Myocardial Infarction

IFCC Task Force on Clinical Applications of Cardiac Biomarkers (TF-CB) Report to the General Conference 2016 Madrid

Bertil Lindahl Akademiska sjukhuset Uppsala

High-sensitivity Troponin T Predicts Recurrent Cardiovascular Events in Patients with Stable Coronary Heart Disease: KAROLA Study 8 Year FU

International Journal of Cardiology and Cardiovascular Research Vol. 4(2), pp , September, ISSN:

Impact of Troponin Performance on Patient Care

Current Utilities of Cardiac Biomarker Testing at POC. June 24, 2010 Joe Pezzuto, MT (ASCP) Carolyn Kite, RN

DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, "G. PAPANIKOLAOU" GH, THESSALONIKI

Challenging Issues in Cardiac Biomarker interpretation. F. Nikaeen. MD interventional Cardiologist

EDUCATIONAL COMMENTARY UNDERSTANDING THE BENEFITS AND CHALLENGES OF HIGH- SENSITIVITY TROPONIN TESTING IN CLINICAL AND PATHOLOGY SETTINGS

Waiting for High-Sensitivity POCT Cardiac Troponin Assays: Clinical and Analytical Needs I Have a Pain in My Chest That Hurts Very Bad

Hit the road Jack! W. FRANK PEACOCK, MD, FACEP, FACC

Myocardial Injury after Noncardiac Surgery (MINS): What is it and what can we do to help patients suffering this event? PJ Devereaux, MD, PhD

TROPONINS HAVE THEY CHANGED YOUR

CLINICAL GUIDANCE FRAMEWORKS

Study of clinical presentations of acute myocardial infarction in Indian Population

Does serial troponin measurement help identify acute ischemia/ischemic events?

Chest Pain Wave I Webinar. May, 30 th 2017

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

VCU HEALTH SYSTEM EMERGENCY DEPARTMENT GUIDELINE

Fifty shades of Troponin. Dr Liam Penny The Queens Hotel, Cheltenham 4 th October 2012

Är dagens troponinmetoder tillräckligt känsliga?

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis.

Chest Pain. Dr Robert Huggett Consultant Cardiologist

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

CCS Perioperative Guidelines When to order a BNP and What to do with a Positive Troponin

Setting The setting was secondary care. The economic study was carried out in Hong Kong.

REFERENCE CODE GDHCER PUBLICAT ION DATE JULY 2014 ACUTE CORONARY SYNDROME (ACS) - EPIDEMIOLOGY FORECAST TO 2023

New universal definition of myocardial infarction

High-Sensitivity Troponin and the Diagnosis of NSTEMI in Hospitalized Medical Patients

Diagnostic effectiveness of high-sensitivity troponins

I have nothing to disclose.

Tests I Wish You Had Not Ordered. Scott Girard D.O. FACOI Hospitalist

Antithrombotic therapy in CAD patients with concomitant NAFV: why and for whom?

Rapid rule out of acute myocardial infarction: novel biomarker-based strategies

Approach to Multi Vessel disease with STEMI

Value of troponin measurements in carotid artery revascularization

The patient with 30 min chest pain presenting at the ER two hours after onset of symptoms. Professor Christian Mueller

High Value Evaluation of Chest Pain. Zoom Tips

Acute Coronary Syndrome

Troponin Assessment. Does it Carry Clinical Message? Stefan Blankenberg. University Heart Center Hamburg

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice

Mario Cavazza Medicina d Urgenza e Pronto Soccorso Azienda Ospedaliero Universitaria di Bologna

Continuing Medical Education Post-Test

Heart-type fatty acid-binding protein in early diagnosis of acute myocardial infarction in comparison to sensitive troponin I

Emergency Medicine Updates. Dr. Timothy Cobb March 1, 2018

ACCESS hstni SCIENTIFIC LITERATURE

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

Document Version Publisher s PDF, also known as Version of Record (includes final page, issue and volume numbers)

Unnecessary hospitalisation and investigation of low risk patients presenting to hospital with chest pain

Peri-operative Troponin Measurements - Pathophysiology and Prognosis

The Value of Stress MRI in Evaluation of Myocardial Ischemia

Rapid detection of myocardial infarction with a sensitive troponin test Scharnhorst, V.; Krasznai, K.; van 't Veer, M.; Michels, R.

Speaker: Richard Heitsman, MICT, C-POC-AACC. Title: National Account Manager/Clinical Cardiac Specialist-Radiometer America.

Transcription:

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung, MD, PhD; Magnus Johansson, MD, PhD; Martin Holzmann, MD, PhD. Department of Emergency Medicine Karolinska University Hospital and Karolinska Institute Stockholm, Sweden Late Breaking Clinical Trial, ACC.14, Washington

Disclosure information No conflicts of interest.

Background Chest pain is one of the most common reasons for seeking medical attention in Emergency Departments (ED) with an estimated 15 20 million visits each year in Europe and the U.S. Only 10-20% of patients hospitalized for chest pain are diagnosed with MI Unnecessary admissions are a burden for health care providers

Background The cornerstone of diagnosing MI is the ECG and biomarkers indicating myocardial damage, commonly cardiac troponins Recently high-sensitivity cardiac troponin assays have been introduced in clinical practice They are able to detect minimally increased levels of troponins in the blood several hours before older generations of troponin assays Repeated measurements of hs-ctnt may not be necessary

Hypothesis All patients with chest pain, who have an undetectable high-sensitivity cardiac troponin T (< 5 ng/l), and an ECG without signs of ischemia, may be discharged directly from the emergency department (ED), since their risk of MI within 30 days is minimal.

Setting and Study population All patients, > 25 years of age, who came to the emergency department at the Karolinska University Hospital in Stockholm, Sweden, with a principal complaint of chest pain, and at least one hs-ctnt level analyzed, during December 10, 2010 to December 31, 2012 were included

Methods High sensitivity cardiac troponin T (hs-ctnt) Elecsys 2010 system (Roche Diagnostics GmbH, Mannheim, Germany) Detection limit of 2 ng/l, 99th-percentile cutoff point of 14 ng/l Coefficient of variation is <10% at 13 ng/l

Methods Exposure A first hs-ctnt < 5 ng/l (undetectable) in the ED, in combination with an ECG without significant STelevation or depression All ECGs for patients with undetectable hs-ctnt and MI were evaluated by two external senior cardiologists blinded for the study protocol

Methods Outcome Primary outcome: Fatal or non-fatal MI within 30 days Secondary outomes: MI at 180, and 365 days all-cause mortality at 30, 180 and 365 days

Study population 330 000 ED visits / 2 years Study period 2010-2012 Age > 25, chest pain, hs-ctnt analyzed n=14 636 4,4% Hs-cTnT < 5 ng/l 61% 5 14 ng/l 21% > 14 ng/l 18% Admitted Discharged Admitted Discharged Admitted Discharged 21% 79% 44% 56% 82% 18%

Results patient characteristics High-sensitivity Cardiac Troponin T level (ng/l) All patients <5 5-14 >14 Number of patients 14 636 8 907 3 150 2 579 Percent of cohort 100 61 22 18 Age (y) 55 47 63 71 Female sex, (%) 48 53 41 37 Diabetes (%) 10 5 14 21 Prior MI (%) 9 4 14 39 Prior Stroke (%) 5 2 7 13 Prior CHF (%) 6 1 8 22

Patients with undetectable hs-ctnt and MI within 30 d. MI n=39 No ECG changes n=15 ECG changes n=24 NSTEMI n=11 STEMI n=4 Maximum hs-ctnt < 30 ng/l, n=6 40 100 ng/l, n=3 >100 ng/l, n=2 Coronary Angiography n=11

Timing of hs-ctnt level analysis in MI patients with undetectable hs-ctnt and ECG without ischemia The first hs-ctnt level was measured within 2 h of the onset of symptoms in 11 (73%) patients, between 2 to 3 hours in 2 (13%) patients, and >3 h after the onset of symptoms in 2 (13%) patients.

Risk of Myocardial Infarction Myocardial infarction High-Sensitivity Cardiac Troponin T level (ng/l) <5 5-14 >14 30 days Number of events 15 97 676 Negative pred. val. 99,8 (99,7-99,9) 96,9 (96,3-97,5) 73,8 (72,1-75,5) 365 days Number of events 54 134 753 Negative pred. val. 99,4 (99,2-99,5) 95,7 (95,0-96,5) 70,8 (69,0-72,6)

Risk of death in patients with undetectable hs-ctnt There were 2 deaths within 30 days The NPV for death was 100% (99.9-100) At 1 year of follow-up there were 38 deaths, of whom 32 were caused by cancer and 2 were cardiovascular

Discharge diagnosis in patients with undetectable hsctnt who were admitted 77% of admitted patients were discharge the same or the next day, In patients with undetectable hs-ctnt 50% had a discharge diagnosis of unspecific chest pain, the second most common diagnosis was atrial fibrillation (6%), the third most common diagnosis was angina pectoris (5%)

Clinical Implications Unnecessary admissions may be avoided May help diminish overcrowding of the ED Saving time for the patient and the doctor

Conclusion A first hs-ctnt level of <5 ng/l and no signs of ischemia on ECG ruled out MI with nearly 100% accuracy regardless of prior disease, timing of measurement of the hs-ctnt level, age, sex, or other risk factors for MI, The negative predictive value for death associated with an undetectable hs-ctnt and an ECG without signs of ischemia was 100%, Only in our hospital this simple strategy may prevent 500 to 1000 unnecessary hospitalizations per year

Thank you ACC.14